Anavex Life Sciences Corp. (0HFR.L) LSE

9.67

-0.4611(-4.55%)

Updated at August 18 06:06PM

Currency In USD

Valuation

Market Cap474.1M
Enterprise Value341.91M
P/E Ratio-23.44
PEG Ratio6.45
Price/Sales Ratio0
Price/Book Ratio9
Enterprise/Revenue0
Enterprise/EBITDA-10.15

Fiscal Year

Fiscal YearSeptember 30, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.34
Return On Equity-0.33

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-45.29M
Net Income-43M
Diluted EPS-0.52

Balance Sheet

Total Cash101.16M
Total Cash/Share1.18
Total Debt0
Total Debt/Equity0
Current Ratio13.41
Book Value Per Share1.07

Price History

52-Week Change58.28
52-Week High10.45
52-Week Low4.8
Moving Average 50 Days5.79
Moving Average 200 Days7.24

Statistics

Average Volume7,784
Shares Outstanding85.89M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A